In 2018 the United States invested $371 million in tuberculosis research and development (R&D). South Africa invested $4.5 million (R64,9 million) – a dramatic decrease on 2017, but still high when measured as a proportion of all R&D spending in the country.
Each of South Africa’s nine provinces is supposed to have an HIV and TB plan that guides provincial implementation of the National Strategic Plan. Here’s Spotlight’s analysis of KwaZulu-Natal’s plan.
At the start of the nineties, very few doctors were willing to take up the fight against TB. Faced with the option of Oncology or TB, Van Rensburg opted for TB. She is still at the coal face of the TB fight in Klerksdorp. Nomatter Ndebele and Thom Pierce went to meet her.
Last week the Conference for Retroviruses and Opportunistic Infections (CROI) was held in Seattle, USA. Spotlight did not attend this year’s conference, but fortunately all CROI abstracts and presentations are made available online. Below we have picked some highlights of relevance for South Africa.